Effects of topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride on corneal sensitivity in rats

PLoS One. 2020 Nov 5;15(11):e0241567. doi: 10.1371/journal.pone.0241567. eCollection 2020.

Abstract

The aim of the present study was to determine and compare the degree and duration of corneal anesthesia following topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution and 1% ropivacaine hydrochloride treatment in healthy rats. A randomized, blinded, crossover study was conducted on 20 healthy adult Wistar rats, following complete physical and ophthalmological examination. Baseline corneal touch threshold (CTT) was determined in the central corneal area of both eyes with a Cochet-Bonnet aesthesiometer, in mm filament length. Oxybuprocaine was randomly applied to one eye and 0.9% sterile sodium chloride solution was instilled into the contralateral eye. Subsequent CTT measurements were performed in both eyes 5 minutes after topical application and at 5-minute intervals thereafter for 75-minutes in the anesthetized eye. Following a 2-week washout period, this protocol was repeated with ropivacaine. Quantitative data were summarized as mean ± standard deviation, median and inter-quartile range (Q1-Q3). Repeated measures data were analyzed over time and between treatments using Friedman test and Wilcoxon signed-rank test with Bonferroni adjustment (p < 0.05). Baseline CTT values were 60 mm in all eyes. With oxybuprocaine, CTT values decreased significantly for 65 minutes (0-55 mm; p = 0.002) when compared with baseline; the maximal anesthetic effect (no blink response at 5 mm filament length) was maintained for up to 15 minutes (p < 0.0001). With ropivacaine, CTT values were significantly lower than baseline for 30 minutes (0-55 mm; p = 0.002), with a maximal anesthetic effect recorded at 5 minutes in 18 eyes (p < 0.0001). Oxybuprocaine induced a significantly lower CTT than ropivacaine (p = 0.002) from 10 to 65 minutes following topical application. Both anesthetic agents induced significant corneal anesthesia; however, oxybuprocaine provided a greater and longer anesthetic effect, making it more suitable for potentially painful ophthalmologic procedures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Animals
  • Cornea / drug effects*
  • Female
  • Male
  • Ophthalmic Solutions / administration & dosage*
  • Ophthalmic Solutions / pharmacology*
  • Procaine / administration & dosage
  • Procaine / analogs & derivatives*
  • Procaine / pharmacology
  • Rats, Wistar
  • Ropivacaine / administration & dosage*
  • Ropivacaine / pharmacology*
  • Sensory Thresholds / drug effects

Substances

  • Ophthalmic Solutions
  • Procaine
  • Ropivacaine
  • benoxinate

Grants and funding

The publication was supported by funds from the National Research Development Projects to finance excellence (PFE) granted by the Romanian Ministry of Research and Innovation and awarded to CM (37/2018–2020). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.